Grace Davison has received a 2009 R&D 100 Award for its REVELERIS system, a flash chromatography system that streamlines the purification of new chemical/biological entities, thus enabling the discovery of new medicines.
"Having our product selected as one of the top 100 innovations of the year by R&D Magazine's panel of expert judges is an honor and confirmation of our ability to innovate the next generation of products," said Fred Festa, Chairman, President and CEO.
The REVELERIS system is the result of Grace's expertise in material science, detector technology and continued investment in R&D. Joanne Green, VP of Grace Davison Discovery Sciences, explains, "A global product development effort was made to address an unmet need in the marketplace: helping synthetic and medicinal chemists streamline purifications of mixtures during the design and synthesis of promising new chemical entities. We drew upon wider industry expertise and sought specific 'voice of customer' input when designing the product's features. Today, we're proud to receive this R&D 100 award as an affirmation of our innovation." More info at www.rdmag.com.
For decades, flash chromatography has been the primary technique used to purify new entities in the early stages of drug discovery. The purified compounds are then tested for their potential to be viable new drug candidates.
The REVELERIS system uses proprietary RevealX detection and SRC cartridge technologies to yield more samples with fewer impurities in less time, allowing pharmaceutical companies to bring important new drugs to market more quickly.
Source: Grace Davison